Cellectis

Allogeneic CAR-T biotechs fight to escape 'nuclear winter'

As autologous CAR-T continues to improve and Big Pharma pumps big cash into next-gen approaches, is there room left at the table for allogeneic CAR-T?

Darren Incorvaia Feb 11, 2026 11:00am

Cellectis drops one of its 3 clinical-stage CAR-Ts

Nov 5, 2024 7:15am

A stock ticker showing financial information

AstraZeneca takes 22% stake in Cellectis under 10-asset collab

Nov 1, 2023 8:45am

Cellectis culls CAR-T over cost of kick-starting slow trial

May 5, 2023 8:20am

dandelion flower bloom seeds spring sunset field

Mayo Clinic cell and gene therapy accelerator launches startup

Jan 3, 2023 9:50am

Servier severs CAR-T collab with Allogene

Sep 22, 2022 10:23am